Premium
DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN LATE‐OCTOGENARIAN (LO) PATIENTS: A SUBSTUDY OF THE “ELDERLY PROJECT” BY THE FONDAZIONE ITALIANA LINFOMI (FIL)
Author(s) -
Tucci A.,
Merli F.,
Fabbri A.,
Mancuso S.,
Sartori R.,
Storti S.,
Luminari S.,
Mammi C.,
Marcheselli L.,
Arcari A.,
Cavallo F.,
Zilioli V. R.,
Bottelli C.,
Re A.,
Gini G.,
Cox M. C.,
Puccini B.,
Pagani C.,
Balzarotti M.,
Spina M.,
Rossi G.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.95_2880
Subject(s) - medicine , anthracycline , clinical endpoint , diffuse large b cell lymphoma , lymphoma , bristol myers , clinical trial , cancer , breast cancer